Banham John Michael Middlecott Insider Trades

Insider Trading History

Track insider trading activity for Banham John Michael Middlecott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Director
Holding Value $26.3k 5,200 shares
Last Trade
Jun 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.4k 5,200 shares
$6.03
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $33.1k 5,200 shares
Last Trade
Jun 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.9M 5,200 shares
$16,911.54
$6.36
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Holding Value $94.7k 18,750 shares
Last Trade
May 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.7k 18,750 shares
$4.89
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $119k 18,750 shares
Last Trade
May 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$864M 18,750 shares
$46,056.96
$6.36
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $54.6k 8,576 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$876M 8,576 shares
$102,188.88
$6.36
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Holding Value $43.3k 8,576 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.9k 8,576 shares
$6.05
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $12.7k 2,000 shares
Last Trade
May 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630M 2,000 shares
$315,202.32
$6.36
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Holding Value $10.1k 2,000 shares
Last Trade
May 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 2,000 shares
$6.25
$5.05
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Holding Value $75.8k 15,000 shares
Last Trade
May 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69k 15,000 shares
$4.60
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $95.5k 15,000 shares
Last Trade
May 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.56B 15,000 shares
$370,359.69
$6.36
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $95.5k 15,000 shares
Last Trade
May 22, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4B 15,000 shares
$691,130.74
$6.36
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $95.5k 15,000 shares
Last Trade
May 22, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4B 15,000 shares
$691,130.74
$6.36
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $57.3k 9,000 shares
Last Trade
May 22, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24B 9,000 shares
$2,669,492.49
$6.36
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $57.3k 9,000 shares
Last Trade
May 22, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24B 9,000 shares
$2,669,492.49
$6.36
Invesco
Invesco IVZ
Director
Holding Value $567k 20,112 shares
Last Trade
May 02, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 1,008 shares
$35.96
$28.17
Invesco
Invesco IVZ
Director
Holding Value $538k 19,104 shares
Last Trade
Jan 31, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 714 shares
$33.25
$28.17
Invesco
Invesco IVZ
Director
Holding Value $518k 18,390 shares
Last Trade
Nov 15, 2013 Sale (Open Market)Shares sold on the open market or in a private sale.
$134k 3,975 shares
$33.79
$28.17
Invesco
Invesco IVZ
Director
Holding Value $630k 22,365 shares
Last Trade
Nov 01, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 701 shares
$33.84
$28.17
Invesco
Invesco IVZ
Director
Holding Value $610k 21,664 shares
Last Trade
Aug 01, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 718 shares
$33.04
$28.17
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $31.8k 5,000 shares
Last Trade
May 22, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.9B 5,000 shares
$2,583,101.15
$6.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up